CATALOGO DEI PRODOTTI DELLA RICERCA

RIBICHINI, Flavio Luciano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.244
EU - Europa 14.758
AS - Asia 11.873
SA - Sud America 1.758
AF - Africa 420
Continente sconosciuto - Info sul continente non disponibili 343
OC - Oceania 38
Totale 46.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.860
RU - Federazione Russa 6.574
SG - Singapore 5.090
CN - Cina 3.135
GB - Regno Unito 2.457
BR - Brasile 1.383
IT - Italia 1.272
HK - Hong Kong 1.055
VN - Vietnam 1.009
FR - Francia 828
DE - Germania 822
IE - Irlanda 713
SE - Svezia 659
FI - Finlandia 634
KR - Corea 423
BD - Bangladesh 217
UA - Ucraina 214
CA - Canada 187
IN - India 172
AR - Argentina 126
JP - Giappone 110
NL - Olanda 104
MX - Messico 101
ID - Indonesia 93
TR - Turchia 89
ZA - Sudafrica 84
PL - Polonia 80
NG - Nigeria 73
IQ - Iraq 71
ES - Italia 68
TG - Togo 67
EC - Ecuador 63
PK - Pakistan 57
AT - Austria 51
BE - Belgio 51
CO - Colombia 46
BJ - Benin 44
UZ - Uzbekistan 39
VE - Venezuela 39
IR - Iran 34
MA - Marocco 34
PH - Filippine 33
SA - Arabia Saudita 33
EG - Egitto 32
AU - Australia 30
CL - Cile 29
LT - Lituania 28
PY - Paraguay 28
JO - Giordania 26
RO - Romania 26
CZ - Repubblica Ceca 25
AE - Emirati Arabi Uniti 20
MY - Malesia 20
PE - Perù 20
TN - Tunisia 20
IL - Israele 19
AZ - Azerbaigian 18
CH - Svizzera 16
OM - Oman 16
DZ - Algeria 15
JM - Giamaica 15
CR - Costa Rica 14
GR - Grecia 13
KG - Kirghizistan 13
AL - Albania 11
GT - Guatemala 11
PA - Panama 11
UY - Uruguay 11
BY - Bielorussia 10
GE - Georgia 10
HU - Ungheria 10
KZ - Kazakistan 10
NP - Nepal 10
PT - Portogallo 10
SI - Slovenia 10
BO - Bolivia 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
AO - Angola 7
BG - Bulgaria 7
EE - Estonia 7
HN - Honduras 7
LB - Libano 7
NO - Norvegia 7
RS - Serbia 7
TH - Thailandia 7
CG - Congo 6
KE - Kenya 6
LV - Lettonia 6
NI - Nicaragua 6
PS - Palestinian Territory 6
CI - Costa d'Avorio 5
ET - Etiopia 5
HR - Croazia 5
MD - Moldavia 5
TT - Trinidad e Tobago 5
CY - Cipro 4
GY - Guiana 4
KH - Cambogia 4
LU - Lussemburgo 4
Totale 46.003
Salva come PNG Salva come JPEG
Città #
Singapore 2.676
Moscow 2.183
Ashburn 2.097
Southend 2.004
San Jose 1.669
Jacksonville 1.482
Chandler 1.371
Dallas 1.286
Hong Kong 1.042
Woodbridge 905
Dublin 701
Council Bluffs 643
The Dalles 575
Verona 555
Beijing 543
Ann Arbor 533
New York 514
Houston 432
Los Angeles 341
Ho Chi Minh City 331
Lawrence 277
Princeton 277
Munich 254
Wilmington 254
Hanoi 248
Helsinki 225
Jinan 211
Nanjing 163
Shenyang 155
Buffalo 137
Santa Clara 137
Redondo Beach 135
São Paulo 133
Hebei 130
Tianjin 114
Columbus 104
Milan 97
Seattle 92
London 88
Sindelfingen 82
Tokyo 76
Guangzhou 75
Changsha 74
Nanchang 70
Frankfurt am Main 69
Montreal 69
Washington 69
Lomé 66
Orem 66
Zhengzhou 65
Abuja 64
Warsaw 63
Atlanta 62
Haikou 62
Seoul 62
Rio de Janeiro 59
Chicago 58
Hangzhou 57
Turku 57
Amsterdam 55
Brooklyn 55
Johannesburg 55
Stockholm 55
Denver 54
Taizhou 52
San Francisco 51
Boardman 50
Brussels 49
Taiyuan 49
Ningbo 48
Nuremberg 48
Phoenix 48
Haiphong 47
Norwalk 47
Chennai 46
Rome 46
Toronto 45
Cotonou 44
Fuzhou 43
Jiaxing 43
Redwood City 37
Baghdad 36
Da Nang 36
Tashkent 35
Boston 33
Poplar 33
Belo Horizonte 32
Redmond 32
Bologna 31
Fairfield 31
Mexico City 30
Brasília 29
Falkenstein 29
Jakarta 29
Kent 29
Lanzhou 27
Shanghai 27
Biên Hòa 25
City of London 25
Falls Church 25
Totale 28.080
Salva come PNG Salva come JPEG
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 591
Angiography-Derived and Sensor-Wire Methods to Assess Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction 259
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 232
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 221
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 217
Accuracy of Micro-Computed Tomography in Post-mortem Evaluation of Fetal Congenital Heart Disease. Comparison Between Post-mortem Micro-CT and Conventional Autopsy 214
[The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory]. 210
A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. 208
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 207
[Bypass surgery versus percutaneous coronary intervention: evidence, indications and patient preference according to the latest European guidelines on myocardial revascularization] 207
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 207
First successful management of aortic valve insufficiency associated with HeartMate II left ventricular assist device support by transfemoral CoreValve implantation: the Columbus's egg? 206
[Emergency angioplasty in high-risk acute infarct]. 201
[Analysis of right electrocardiographic leads in 195 normal subjects]. 200
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. 199
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 197
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 195
Effects of Aortic Valve Replacement on Left Ventricular Diastolic Function in Patients With Aortic Valve Stenosis 195
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 194
[Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct]. 194
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 192
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. 190
Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity 190
Hemodynamic predictors of long term survival in end stage cystic fibrosis 188
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 187
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization 187
Drug-coated balloon: Long-term outcome from a real world three-center experience 187
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 186
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 185
A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease: The EXECUTIVE Trial (EXecutive RCT: Evaluating XIENCE V in a Multi Vessel Disease). 184
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 184
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis 182
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 181
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 180
[Heart catheterization via the femoral artery with a 4 French and mobilization at 2 hours]. 178
Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer 178
Clinical impact of mitral regurgitation in aortic valve stenosis: Insight from effective regurgitant orifice area 178
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 177
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 177
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 177
Early functional and structural changes of the left atrium in a patient with trastuzumab: related cardiotoxicity 176
In-stent restenosis. 175
[Radiologic practice and radioprotection in Italian hemodynamic laboratories]. 175
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives 175
Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis 175
Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to and Support for Pulmonary Thromboendarterectomy in Misdiagnosed Chronic Thromboembolic Pulmonary Hypertension 174
[Elective coronary angioplasty in total absence of heart surgery]. 173
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 173
[Technical features of Absorb(TM) BVS implantation in the IT-DISAPPEARS registry] 173
The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention 171
[Primary angioplasty in acute inferior myocardial infarct with anterior ST-segment depression: the long-term follow-up]. 170
[Invasive cardiological diagnosis in an ambulatory regimen of transported inpatients]. 170
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 169
Midventricular Takotsubo cardiomyopathy complicated by a ventricular septal rupture: a surgical management 168
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 168
Elective coronary angioplasty with and without surgical standby: clinical and angiographic criteria for the selection of patients. 167
Optimizing the role of transthoracic echocardiography to improve the cardiovascular risk stratification: the dream of subclinical coronary artery disease detection 167
Impella-protected PCI: the clinical results achieved so far 167
Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial 167
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 167
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. 166
Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration 165
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 164
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 164
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 163
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 162
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 162
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 162
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 162
[Diagnostic hemodynamics in day-hospital care]. 161
Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study 161
Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy 161
Early atrial fibrillation detection is associated with higher arrhythmic burden in patients with loop recorder after an embolic stroke of undetermined source 159
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 159
First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm 159
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 159
[Quality assurance and cost control in invasive and interventional cardiology]. 157
Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients 157
Excess mortality associated with progression rate in asymptomatic aortic valve stenosis 157
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 154
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 154
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 154
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 153
Role of Speckle Tracking Echocardiography in the Evaluation of Breast Cancer Patients Undergoing Chemotherapy: Review and Meta-analysis of the Literature 153
On the current epidemic outburst of meta-analytic rage in interventional cardiology. 152
Angiography-derived index of microvascular resistance in takotsubo syndrome 152
On-line quantitative coronary analysis in clinical practice: one step closer to reality? 151
Bioresorbable vascular scaffolds in cardiac allograft vasculopathy: a new therapeutic option. 151
Functional mitral regurgitation: are we treating the real target? 151
Angiotensin antagonism in coronary artery disease: results after coronary revascularisation. 150
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI 149
Concomitant myocardial infarction in identical twins with similar coronary lesions. 149
Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial 149
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 149
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 147
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). 147
Long-term variations of FFR and iFR after transcatheter aortic valve implantation 147
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 147
Correlation between epicardial adipose tissue and atrial fibrillation burden in coronary artery bypass graft surgery 146
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries 146
Totale 17.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.433
article - articoli 174.433
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 348.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.551 0 350 15 103 80 47 25 107 67 71 185 501
2022/20234.309 319 454 450 643 351 1.040 91 284 478 22 108 69
2023/20242.862 87 197 277 305 313 595 134 214 23 170 375 172
2024/20257.228 370 414 237 1.182 378 277 353 363 1.186 573 597 1.298
2025/202621.330 1.592 996 1.464 3.633 5.421 1.444 1.963 1.175 1.687 1.035 391 529
2026/2027825 242 583 0 0 0 0 0 0 0 0 0 0
Totale 46.434